FIELD: medicine.
SUBSTANCE: invention refers to medicine and oncology, and concerns a biotherapy method of lab rats with grafted glioblastoma. That is ensured by introducing once day for 7 days of granulocyte colony-stimulating factor 4 mg per 140–160 g of body weight and bacterial lipopolysaccharide in amount of 5 mg per kg of body weight of rat, and 4 hours after administering the last dose of bacterial lipopolysaccharide, 9 mg of interferon-γ is administered once.
EFFECT: invention allows suppressing production of TGF-β1 in a grafted glioblastome of laboratory rats and localizing a tumor center.
3 cl, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT | 2019 |
|
RU2794261C2 |
| ANTITUMOR TARGET CELL PRODUCT, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2018 |
|
RU2757812C2 |
| UNIVERSAL PROMOTER FOR EXPRESSION OF THERAPEUTIC GENES IN MAMMALIAN CELLS | 2013 |
|
RU2551784C1 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| IMPROVED COMPOSITION FOR INHIBITION OF TUMOUR CELL PROLIFERATION | 2011 |
|
RU2565542C2 |
| METHOD OF STIMULATING PRODUCTION OF GRANULOCYTE COLONY STIMULATING FACTOR BY BONE MARROW CELLS IN VITRO | 2013 |
|
RU2527888C1 |
| METHOD OF EARLY MOLECULAR-BIOLOGICAL DIAGNOSIS OF MALIGNANT GROWTHS AND AMYOTROPHIC LATERAL SCLEROSIS | 2018 |
|
RU2706714C1 |
| STEM CELL PREPARATION WITH REPROGRAMMED CELL SIGNALLING, METHOD FOR MAKING THIS PREPARATION AND APPLICATION THEREOF | 2008 |
|
RU2428475C2 |
| COMPOSITION FOR NEUROPROTECTION AND STIMULATION OF BRAIN NEUROREGENERATION AFTER INJURY, AGENT BASED ON IT, A METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2803286C1 |
| TARGETED COLONY-STIMULATING AGENT | 2020 |
|
RU2749509C1 |
